ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNGO vs EYPT // EV/EBITDA & P/E VALUATION

Bionano Genomics Inc. (NASDAQ) VS. EyePoint Inc. (NASDAQ) • 15-METRIC TALLY: BNGO 3 — EYPT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNGO VS. EYPT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNGO EYPT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 46.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -7.40% -27.50% +20.10 BNGO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 BNGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.4 15.7 +18.78 BNGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.8M $32.8M -$16.0M EYPT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNGO REV EYPT REV BNGO GROSS % EYPT GROSS % BNGO FCF EYPT FCF
FY 2025 $28.5M $31.4M 46.3% — -$16.3M -$243.4M
FY 2024 $30.8M $43.3M 1.2% — -$68.9M -$130.3M
FY 2023 $36.1M $46.0M — — -$125.2M $1.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNGO // BETA —
EYPT // BETA —